INTRODUCTION

Inhibition of Fibrotic Contraction by C-Phycocyanin through Modulation of Connective Tissue Growth
Factor and α-Smooth Muscle Actin Expression the fibrotic response. Fibroblasts display considerable variation during wound repair [13] .
Fibroblastic cells acquire contractile properties during the healing of an open wound, modulating into myofibroblasts [14] . Myofibroblasts express the smooth muscle actin isoform. During normal wound repair, myofibroblasts are transiently present at the wound site causing wound contraction and restoration of tissue integrity. Once the wound has regained normal structure and function, myofibroblasts disappear by apoptosis. In pathological states, myofibroblasts persist and produce excess of extracellular matrix deposition and tissue deformation leading to scarring [15] . Even though myofibroblasts are crucial for proper wound repair, their timely disappearance is crucial for preventing undesirable scarring process [16, 17] . And connective tissue growth factor (CTGF) in early wound healing stage has beneficial effects in collagen production and proper organizing and epithelialization [18] . However, sustained over-expression of CTGF induced fibrosis [19] . CTGF elevation has been implicated in number of fibrotic lesions. Recent studies have demonstrated that in addition to its direct effect on extracellular matrix turnover, it may stimulate fibroblast to myofibroblast differentiation, as it is capable of up-regulating α-smooth muscle actin (α-SMA) in fibroblast.
Prostaglanding E2 (PGE2) has been shown to prevent multiple aspects of fibroblast activation, including the differentiation of fibroblasts to myofibroblasts. C-pc, a COX-2 inhibitor prevented PGE2 synthesis in a dose dependent manner and preventing fibrosis [20] . PGE2 exerts an important anti-fibrotic effect by increasing the sensitivity of fibroblast/myofibroblast to apoptosis [21] . C-pc mediated apoptosis in AK-5 tumor cells and prevented cancer cell proliferation [22] . Conversely, increased fibroblast proliferation and enhanced wound closure with upregulation of collagen in C-pc-treated (75 µg/mL) group were reported [23] . The validity of the wound healing effect and anti-scarring effect of C-pc remains to be clarified.
In this study, we investigated how anti inflammatory effect of C-pc could modify the outcome of wound healing, scar disposition. The effect of C-pc on α-SMA and CTGF, a pro-fibrotic mediators involved in hyper-tropic scarring were investigated in relation with modulation of trans-differentiation of fibroblast to myofibroblast, an icon of scar formation.
MATERIALS AND METHODS
Materials
All chemicals were purchased from Sigma chemicals (MO, USA). Human dermal fibroblast was provided from dept. dermatology, Seoul National University. Spirulina platensis was provided from Korea Institute of Ocean Science and Technology (KIOST). Dulbecco's Modified Eagle Medium (DMEM) culture medium and fetal bovine serum (FBS) were purchased from Cellgro (Washington DC, USA), penicillin streptomycin was purchased from Gibco (New York, NY, USA) and Cultrex ® Rat Collagen I was purchased from Trevigen (Gaithersburg, MD, USA).
Extraction of C-phycocyanin from Spirulina platensis
The Spirulina platensis powder (KIOST, Ansan, Korea) was suspended in 10 mL of 0.1M buffer (sodium phosphate buffer, pH=7). C-pc was extracted by the established standard process. In brief, the suspension was processed by 1 min vortex, 1 min sonication and 1 min vortex. The suspension was stored at 4°C for 4 hr. The mixture was then centrifuged at 2500 rpm for 5 min and repeated 3 times. The C-pc containing clear blue supernatant was collected. The absorbance of phycobiliprotein containing supernatant was measured by UV Spectroscopy (SmartSpec TM 3000 Spectrophotometer, BIO-RAD Inc., Hercules, CA, USA). The C-phycocyanin concentration (C-pc) in mg/mL was calculated from the optical densities at 652 and 620 nm, using the previously reported following Bennett and Bogorad equation [24] .
C-pc concentration= OD620-0.474×OD652 5.34
Cell lines
Primary human foreskin fibroblasts were provided from professor KC Park, department of dermatology, Medical school, Seoul National University. Fibroblasts were cultured in a 6 well plate (5×10 5 cells/well) in DMEM medium supplemented with 10% heat inactivated FBS and 100 units/mL penicillin/streptomycin. Cells were maintained in a humidified atmosphere with 95% air and 5% CO2 at 37°C.
In vitro wound healing study
In vitro fibroblast wound model was prepared as reported previously [25] . In brief, cells were plated in six-well plates at 1×10 5 cells/well confluence and grown for 24 hr. After scratching with a sterile 10 µL micro tip, cells were treated with C-pc for predetermined time points (3-6 hr) in incubator. After treating with C-pc, cell morphology, cell migration and proliferation were observed and images were captured and analyzed with Olympus microscopy system composed of an inverted microscope (OLYMPUS CK40, Olympus, Tokyo, Japan) and Camera (Olympus C-3030, Olympus, Tokyo, Japan).
CTGF immunoblot analysis
After 6 hr C-pc treatment, cells were rinsed with cold phos-phate buffer solution (PBS) and lysed in sodium dodecyl sulfate (SDS)-lysis buffer. Equal amounts of protein extracts in SDS-lysis buffer were subjected to 12% SDS-polyacryl amide gel electrophoresis (PAGE) analysis and electrophoretically transferred to nitrocellulose membrane. Anti-CTGF antibody was purchased from Santa Cruz (CA, USA). β-actin antibody was from Sigma-Aldrich (MO, USA). Enhanced chemiluminescence (Amersham Pharmacia, Buckinghamshire, UK) system was used for detection. Relative intensity of the bands was determined by an Image Analyzer Gel Logic 200 Imaging System (NY, USA).
α-SMA western blot analysis
After scratching with a sterile 10 µL micro tip, cells were cultured with and without C-pc in the absence of FBS. The cells are washed 2-3 times with cold PBS. Each well was added 70-80 µL lysis buffer [1 M tris (pH 6.8) 500 µL, 10% SDS 2 mL, 0.5 M ethylenediamine tetraacetic acid (pH 8.0) 20 µL, 1 M DDT 1 mL, protease inhibitor 1 tab, D.W 5.48 mL; total 10 mL] to prepare a supernatant. The concentration of the supernatant was measured by Bradford method using Protein Assay Reagent (Bio-Rad Inc., Hercules, CA, USA). The protein were separated by SDS-PAGE (10% polyacrylamide), transferred onto polyvinylidene difluoride membrane and probed with specific polyclonal antibodies and secondary antibodies. Protein-antibody complexes were visualized by the enhanced chemiluminescence detection system (Amersham Pharmacia, Buckinghamshire, UK).
Collagen lattice contraction
After cells were cultured with and without C-pc for 6 hr, control and C-pc-treated cells were trypsinized. Collagen gel was prepared with 1.4 mL bovine dermal collagen and 0.4 mL 5× DMEM (Sigma, St. Louis, MO, USA) and adjust the pH to 7.2 to 7.5 with NaOH. And 0.2 mL of the cell suspension (containing 5×10 5 cells) was added to the dermal collagen solution. Before making collagen mixture, six-well plate was coated with BSA for 1 hr in incubator. Place the 2 mL collagen mixture into a well of the six-well plate, then, BSA was removed. Collagen lattices were allowed to gel for 60 mins in an atmosphere with 95% air and 5% at 37°C. After 60 mins, the collagen lattices were detached from the surface of the well by rimming the lattice with a sterile spatula. 4 mL of serum-free medium (SFM) was added to each well. And the rate of contraction was determined by measuring lattice diameter at predetermined time.
Confocal immuno-fluorescence analysis
The cells were plated in 8-well-slide glass at 2.0×10 4 cells/well (250 µL) confluence and grown for 16 hr. After scratching with 0.5-10 µL micro tips, the cells were cultured with and without C-pc for 6 hr in incubator. And then tested fibroblast samples were fixed in 3.7% formaldehyde for 1 hr and washed twice in PBS and then placed in 1% Triton X-100 (300 µL/well) for 15 mins and blocked with 10% FBS for 1 hr at room temperature. Following sample preparation, immunohistochemistry was performed for the detection of a-SMA using indirect immunofluorescence with the primary antibody against a-SMA, monoclonal anti-a-SMA-Cy3 conjugated (Sigma, St. Louis, MO, USA) at a dilution of 1:200 in FBS for 16 hr in incubator. Slides were washed twice in PBS. Treated samples were exposed to 4,6-diamidino-2-phenylinodole (DAPI) (Sigma, St. Louis, MO, USA) staining solution at a dilution of 1:5000 for 1 min. DAPI is a blue fluorescent nuclear stain, and this step was ensured to visualize nuclei. The slides were washed twice in PBS, mounted in antifade reagent 10 µL and fixed it with cover slips. Images were viewed with a confocal laser-scanning microscope, Zeiss Laser Confocal Microscope (ZEISS-LSM 700, Jena, Germany).
Statistical analysis
Comparisons of CTGF, α-SMA, collagen lattice contractions among control and C-pc-treated groups were performed using Student's t-test. p value<0.05 and p<0.1 was accepted as denoting statistical significance. Data are expressed as mean±standard deviation.
RESULTS
Physico-chemical properties of C-pc
The water solubility of C-pc extracted from Spirulina Platensis (KIOST) was 4.06±0.45 mg/mL. Partition coefficient (POctanol/ Water) of C-pc was 0.063 (log POctanol/Water=-1.2).
Stability of phyocycnin
After extraction, stability of C-pc at different temperatures was investigated. C-pc maintained its stability when stored at -10°C in nitrogen gas filled vials. During 24 hr period, 5% and 23% loss of C-pc concentration were observed at 4°C and 25°C, respectively. To maintain stability, C-pc was stored at -10°C in nitrogen gas filled vials prior to use.
Effect of C-pc on the trans-differentiation of fibroblasts to myofibroblasts
Scratch-wound model was prepared with human dermal fibroblasts and the effect of C-pc on the trans-differentiation of fibroblast to myofibroblast was investigated. Figure 1 show phase contrast Images of scratched dermal fibroblasts at 9 hr post injury time with (6 nM) or without C-pc treatment. In SFM, C-pc-untreated conditions, large squamous polygonal myofibroblasts (arrow) were observed (Fig. 1A) . In C-pc-treated cells (6 nM), mostly typical biaxial spindle-shaped fibro-blasts (arrow) were observed (Fig. 1B) . This result clearly demonstrates the inhibitory effect of C-pc on the trans-differentiation of fibroblasts into myofibroblasts.
Effect of C-pc on the expression of cytokines
Connective tissue growth factor Figure 2A shows western blot analysis of CTGF in fibroblasts in response to different concentrations of C-pc treatment (0 to 24 nM). Un-wounded (normal) cells express negligible CTGF. CTGF level increased 1.4-fold in wound cells and the level of CTGF was reduced to 50% in C-pc-treated cells (p<0.1). The extent of CTGF expression was dose dependent. Expression of CTGF relative to β-actin, normalized to non-wound is summarized in Figure 2B . The expression of CTGF was reduced in low doses of C-pc-treated cells. CTGF was observed in 6 nM C-pctreated cells. And the extent of CTGF inhibition was leveled down as the C-pc concentration was further increased to 24 nM. The increased expression of CTGF at higher concentration (24 nM) can be explained by comparing with the previous report of significant enhancement of cell migration at higher concentration of C-pc [23] . C-pc-treated groups (75 µg/mL) showed significant up-regulation of hydroxyprolin and collagen content and faster wound closure. High hydroxyl proline content suggests an abundance of myofibroblasts in the wound environment that facilitates collagen deposition and fibroblast migration during the proliferation stage of wound healing. In a contrary, C-pc-mediated apoptosis in Ak-5 tumor cells involves down-regulation of Bcl-2 and generation of ROS was reported [22] . To expect favorable wound healing without scarring, delicate balance between complex networks of many proand anti-inflammatory mediators is crucial [1] . Each panel represents relative CTGF expression in different concentrations of C-pc-treated (0 to 24 nM) wound fibroblast group as compared with normal, un-wounded fibroblasts (B). Statistical significances between C-pc-untreated and treated groups were evaluated using Student's t-test. Bars represent mean±SEM of three replicates per treatment conditions. Statistically different from C-pc-untreated group (0 nM), *p<0.05, **p<0.1.
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Alpha smooth muscle actin Effect of C-pc on α-SMA expression was studied with different concentration ranges (0 to 24 nM). To understand how the scratch wound condition increase the α-SMA expression, unwounded fibroblasts were studied as a comparison. Figure 3A shows western blot analysis of α-SMA in fibroblasts in response to different concentrations of C-pc treatment. Unwounded (normal) cells express negligible α-SMA. Wounded fibroblasts up regulate α-SMA. The extent of α-SMA expression was dose dependent. Expression of α-SMA relative to β-actin, normalized to non-wound is summarized in Figure 3B . The expression of α-SMA was reduced by 36% (p<0.05) in 6 nM and 31% (p<0.05) inhibition in 8 nM C-pc-treated cells. As the concentration of C-pc further increased to 24 nM, the inhibition of α-SMA C was not significant. The less inhibition of α-SMA at higher concentration of C-pc can be explained by that prostaglandin has many isoforms (A to F). Among them, PGE2 has been shown to prevent multiple aspects of fibroblast activation, including the differentiation of fibroblasts to myofibroblasts [20] . Reddy et al. [11] reported that C-pc inhibited PGE2 synthesis in a dose dependent manner; 10 nM (36% inhibition); 30 nM (46% inhibition). C-pc at a concentration of 1 µM inhibited the release of PGE2 to a significant extent (nearly 80% inhibition).
Collagen lattice contraction
The fibroblast-populated collagen lattice (FPCL) contraction assay was used to examine that C-pc could alter fibroblast-mediated contraction of collagen lattices. Figure 4A shows that C-pc inhibited FPCL contraction in a dose-dependent manner. C-pc treatment (6 nM) induced a decrease in contraction rate as compared to the untreated cells. Figure 4B shows the percentage of contraction of FPCL when they were treated with different concentrations of C-pc (0 to 24 nM). Without C-pc treatment, FPCL maintained its initial diameter (50.36±0.02%). C-pc treatment (6 nM) maintained its initial diameter (65.04± 0.01%). The degree of collagen contraction is strongly correlated with α-SMA expression level.
Confocal immunofluorescence analysis
Expression of α-SMA is considered as a marker of myofibroblasts.
Confocal immune-fluorescence analysis was conducted to observe the expression of α-SMA. Figure 5A shows representative confocal sections of immune-fluorescence staining for α-SMA (red) and nuclear staining (blue) with DAPI. Normal, unscratched cells exhibit basal negligent level of α-SMA staining. In the overlaid confocal sections (staining for DAPI and α-SMA) without C-pc treatment, abundance of α-SMA were presented. In contrast C-pc-treated (6 nM) cells show negligible α-SMA staining. This result suggests optimum concentration of C-pc should be carefully selected to expect favorable effect of C-pc. In contrast, there are clear differences in α-SMA immune-reactivity between C-pc-treated and untreated fibroblasts. The untreated cells exhibited cellular hypertrophy and squamous morphology with strong staining of α-SMA and well-formed actin stress fibers. C-pc-treated fibroblasts induced a decrease of α-SMA expression compared to the control untreated fibroblasts. The quantitative comparison of α-SMA western blot analysis with different concentrations (0 to 24 nM) of C-pc treatment was performed. Calculation of the α-SMA expression ratio (number of α-SMA expressed cells/number of DAPI stained cells) was summarized in Figure 5B . The expression of α-SMA was dependent on the concentration of C-pc treatment. After scarring, α-SMA expressing cells increased to 2.4-fold and C-pc treatment (6 nM) reduced the level of α-SMA to Figure 3 . Western blot analysis of α-smooth muscle actins (α-SMA) expression in wounded fibroblasts in response to different concentrations of C-phycocyanin (C-pc) treatment (A). Primary dermal fibroblasts from female human forehead were grown to 80% confluence on 100 mm tissue culture plates, and serum/ growth factor starved for 4 hours. Semiconfluent cultures were treated with C-pc. Expression levels of α-SMA are represented relative to normal, non wound control (B). Bars represent mean± SEM of three replicates per treatment conditions. Statistically different from C-pc-untreated control, *p<0.05, **p<0.1. 
DISCUSSION
To reduce the size of an open wound without scarring, delicate balance between the formation of connective tissue and degradation of excessive extracellular collagen matrix deposition is crucial [26, 27] . In wound healing, the initial stage of healing is cell migration and inflammation followed by cell proliferation, matrix synthesis and resolution. In resolution phase, inflammatory cells undergo apoptosis with a resolution of inflammation and a drop in collagen synthesis so that collagen production is balanced by collagen breakdown. As this balance between collagen production and breakdown disrupted, proliferative scarring occurred [28, 29] . Rinkevich et al. [3] investigated the effects of inhibiting dipeptidyl peptidase, a cell surface serine exopeptidase on scar formation during wound healing using a small molecule (diprotin A), which acts as a selective allosteric inhibitor of CD26 peptidase activity. They reported that complete healing of CD26-inhibitor-treated wounds took 5 days longer than control wounds. Most importantly, although the rate of healing was decreased in inhibitor-treated versus control wounds, treated wounds showed significantly reduced final scar size. It is strongly suggested that faster wound closer implies that there are higher extra collagen matrix disposition (scar) occurs. Down-regulation of α-SMA and CTGF expression and inhibition of myofibroblast persistence observed C-pc-treated group (6 nM) could be explained by the previous reports demonstrating phycocyanin-mediated apoptosis in Ak-5 tumor cells [22] . A recent study also lends support to this notion. Anti-inflammatory effect of C-pc can control the inflammatory signal to macrophage to produce TGF-β which functions as a pro-scarring growth factor [15] . Concentration dependency of C-pc on reduction of fibrotic contraction could be explained by that PGE2 inhibits the differentiation of fibroblasts to myofibroblasts [20] . PGE2 is an important antifibrotic lipid mediator. When there is a failure of induction of COX-2, thus PGE2, fibro-proliferation and fibrosis occurs. Reduced level of PGE2 is found in pulmonary fibrosis patients [21] . C-pc inhibits PGE2 synthesis in a dose dependent manner; 10 nM (36% inhibition); 30 nM (46% inhibition); 1 µM (nearly 80% inhibition) [11] . In this study, we observed that C-pc exhibits dual effects depending on the concentration applied on scratched wound dermal fibroblast model. The less inhibitory effect at high concentration of C-pc-treated group correlates with faster wound closure and high collagen production [29, 30] . The role of C-pc in relation to growth factors and cell migration during wound healing needs further investigation. The concentration dependency of C-pc in anti-scarring effect might be related to the paradoxical status of a pro-inflammatory factor with immune-suppressive activity of prostanglandin E2 [31] . Our study gives the insight to optimize the dose of C-pc for anti scar therapy. However, further study is needed to clarify the role of C-pc in modifying wound healing process and scar prevention in relation with inhibiting PGE2 synthesis.
Conclusion
In this study, we demonstrate that persistence of myofibroblast in wound healing could be inhibited by C-pc treatment. C-pc could modulate the over expression of CTGF, α-SMA and inhibit the fibrotic contracture in scarring process. This study suggests the potential application of C-pc for anti-fibrosis therapy and scar modulating agent.
